CHENGDU, China–(BUSINESS WIRE)–Lipigon Pharmaceuticals AB (”Lipigon”), developer of therapeutics for lipid-related diseases, today announced that the company has expanded its agreement with the Shanghai STAR listed company HitGen Inc. (”HitGen”) to include a second novel target. With joint efforts, the aim is to develop a treatment for cardiometabolic disease. Lipigon […]
Other News
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial
Muhammad Shahzeb Khan, Tariq Jamal Siddiqi, Javed Butler, Tim Friede, Wayne C. Levy, Klaus K. Witte, Janusz Lipiecki, Horst Sievert, Andrew J. Stewart Coats First published: 22 February 2021 https://doi.org/10.1002/ehf2.13273 Abstract Aims The objective of this study was to compare functional outcomes through 1 year in patients with core‐lab verified moderate […]
Biomerics Announces Expansion Of Texas Operations
Expands operations in Texas and breaks ground on new cleanroom facility SALT LAKE CITY, March 8, 2021 /PRNewswire/ — Biomerics, a leading mid-market medical device contract manufacturer, announced it is expanding its manufacturing footprint in Athens, TX. Founded in 1993, Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in […]
AliveCor Appoints Clyde Hosein as Chief Financial Officer
MOUNTAIN VIEW, Calif., March 9, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced the appointment of Clyde Hosein as its Chief Financial Officer. Hosein brings more than 30 years of leadership experience in corporate financial management. He has served as Chief Financial Officer at multiple technology […]
Dr. Devin McCombie leads biotech team to release newest clinical workflow update
The latest ViSi Mobile software update integrates machine learning with increased speed to continue to provide world-class surveillance monitoring which wirelessly communicates critical data to clinicians and identifies physiological deterioration before it becomes a life-threatening event. San Diego, United States , March 09, 2021 (GLOBE NEWSWIRE) — Led by Dr. […]
InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results
Management to host investor conference call today, March 9, at 8:30am ET TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced […]
Corindus Named to Fast Company’s “Most Innovative” List for 2021 Amid Global Expansion
Award recognition coincides with new global installations of CorPath® GRX and U.S. launch of technIQ™ WALTHAM, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, […]
CARMAT Obtains a €1.4 Million Grant as Part of the “Industrial Recovery Plan – Strategic Sectors” Call for Projects
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that is has obtained a €1.4 million grant as […]
Stereotaxis to Establish Global Headquarters in Downtown St. Louis Globe Building
ST. LOUIS, March 08, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it will move its global headquarters to the Globe Building in downtown St. Louis at the end of this year. “Establishing our new headquarters at the Globe is […]
Zynex Announces Share Buyback Program
ENGLEWOOD, Colo., March 8, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that its board of directors approved a program to buy back $10.0 million of the Company’s common stock. The […]



